Treatment Registry
TR-0933 ActiveRecorded October 2026

Compounded tirzepatide

Sold by Blis MD · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit Blis MD

We earn nothing from this link. It opens Blis MD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberLive visit
CancellationNot disclosed
MembershipNot disclosed
Consult feeNone. “Free initial consultation”

Recorded from blismd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Blis lists compounded tirzepatide. Its pricing page advertises $159 monthly, while its weight-loss page starts at $199. Confirm the current offer and payment terms before enrolling. https://blismd.com/pricing and https://blismd.com/weight-loss
  2. 2. October 2026 — The reviewed weight-loss page describes weekly injections but does not establish a vial or pen. Current visit fees, state eligibility and other program terms need confirmation. https://blismd.com/weight-loss

1 further note concerns other Blis MD programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0933
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Blis MD — compounded tirzepatide (TR-0933). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0933

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.